Please login to the form below
Investments show UK biotech still booming despite Brexit
UK raised a quarter of all European biotech funds
Novo uses voucher for speedy answer on oral semaglutide
Oral version of Ozempic could be diabetes market leader
Blood disorder specialists Imara raises $63m
Arix Biosciences claims a 10% stake in the biotech
Liver specialist Genfit files $120m IPO on Nasdaq
Funds will go towards NASH candidate, a companion diagnostic and a liver disease drug
Oxford Biomedica taps Microsoft to progress gene therapy delivery tech
Will develop in silico models and novel algorithms
AZ signs $20m deal with Seres for microbiome project
Shares in Seres shot up 25% after the deal was announced
BMS trades blows with investor on Celgene deal merits
Activist investors claim Celgene’s pipeline is “extremely risky”
Depression drug failure adds to Allergan's woes
Axe hangs over remaining monotherapy and suicidality trials
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
UK biotech bags €1.5m grant for new antibiotic classProcarta is one of four start-ups that received the grant
-
Precision BioSciences to raise $100m for off the shelf CAR-TsJoins next wave of cell therapy competitors
-
Positive data unlocks more EIB funding for Nanobiotix The cash is earmarked for its head and neck cancer drug
-
Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiryWill be joined by chief commercial officer Stuart Arbuckle
-
Biogen strikes $800m deal to buy gene therapy firm NightstarWill also acquire CHM candidate and a therapy for XLRP
-
Horizon sunny as thyroid eye disease drug hits the markNew treatment helps lessen eye bulging
-
Reluctant shareholders threaten $74bn BMS merger with CelgeneShareholders claim merger undervalues BMS but analysts convinced the deal will close
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
Featured jobs
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
-
Senior Medical Writer
-
Salary TBC
-
Health Consultant - Brand Comms
-
Competitive Salary
- Scientific Director – Medical Communications
-
Salary TBC
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
Subscribe to our email news alerts
- Setback for Vertex’s cystic fibrosis challenger Proteostasis
- Celgene hopes for second time lucky for ozanimod FDA filing
- Bluebird plays down report of EU gene therapy approval
- Aimmune preps EU filing for peanut allergy immunotherapy
- DDB Remedy, Cuttsy + Cuttsy and Cello win agency workplace awards
- Janssen looks to expand Darzalex in Europe
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
